• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Segment 5 - Future Directions

Article

In the final segment of the panel discussion, each panel member gave their final thoughts on the discussion topic.

In the final segment of the panel discussion, each panel member gave their final thoughts on the subject at hand. “For the healthcare resources that we have, it’s important for us to start targeting those healthcare dollars towards care that actually makes a difference and improves the health of our patients and the family members,” said Ms Larsen-Haidle. Dr Brawley stated that genetic testing is a complicated area that needs to stay with the experts. Counselors are crucial with the influx of genetic testing today. Counselors, providers, and patients need to work together in order to effectively manage patients.

Related Videos
Chicago skyline with words "CHEST 2025 Recap Chicago, Illinois" | Image credit: SeanPavonePhoto - stock.adobe.com
James Simon, MD – Image credit: AJMC
Brooke Aggarwal, EdD – screenshot by AJMC
Hearn Jay Cho, MD, PhD
Lindsey Valenzuela, PharmD, APh, BCACP – screenshot by AJMC
Dr Brian Koffman
Dr Brian Mulherin
Related Content
Managing metabolic disturbances early in CKD appears to be the most effective approach for reducing the risk of valvular complications. | Image credit: Katie Chizhevskaya - stock.adobe.com

Review Outlines Shared Pathways Between CKD, VHD

October 29th 2025
Article

Overlapping metabolic mechanisms drive both chronic kidney disease (CKD) and valvular heart disease (VHD), a new review outlined.

Read More

The Emerging Landscape of GLP-1 RA Therapies Across Conditions

The Emerging Landscape of GLP-1 RA Therapies Across Conditions

October 14th 2025
Podcast

The founder and President of Phesi addresses the need for streamlining clinical trial data as GLP-1 RA therapies are being used to treat multiple diseases.

Listen

When remission and low-disease-activity states were combined, 68.8% of pathway patients achieved target disease control by 24 months versus 16.7% in usual care. | Image credit: Murrstock - stock.adobe.com

Integrated RA Pathway Improves Outcomes in Real-World Study

October 28th 2025
Article

A multidisciplinary approach that includes addressing social determinants of health reduces time to remission despite higher initial costs.

Read More

Square Podcast Managed Care Cast AJMC_Podcast

How Medicaid Reforms Could Deepen State Coverage Gaps

October 7th 2025
Podcast

Laxmi Patel of Savista discusses how the Budget Reconciliation Act could widen Medicaid coverage gaps and strain hospitals across states.

Listen

Tylenol on store shelf | Image credit: Adriana – stock.adobe.com

Texas Sues J&J, Kenvue for Alleged Deception in Acetaminophen Marketing

October 28th 2025
Article

Attorney General Ken Paxton claims the manufacturers marketed acetaminophen toward pregnant women despite the “known dangers” to unborn children.

Read More

Vivek Subbiah, MD | Image: SCRI

SCRI’s Vivek Subbiah, MD, Highlights Trials on Tumor-Agnostic Cancer Therapies During ESMO

October 28th 2025
Article

Explore the future of cancer treatment with tumor-agnostic therapies, as experts unveil promising trials and innovative drug developments at ESMO.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.